Former MedImmune president Greenleaf tapped to lead Canadian biotech
April 22, 2019 at 14:41 PM EDT
Peter Greenleaf was most recently CEO of Baltimore-based Cerecor Inc., a rare disease therapy company that topped the BBJ's list of fastest-growing public companies last year.